预优化siRNA转染试剂



型号 产品名称- 价格
SL100568-PNN

GenMute™ siRNA Transfection Reagent for Primary Neurons

Description: GenMute™ siRNA Transfection Reagent for Primary Neurons is pre-optimized for transfecting siRNA to primary neurons. Primary neurons are notoriously heard to transfect. With the pre-optimized siRNA transfection conditions, GenMute™ reagent was confirmed to give up to 90% silencing at final 50 nM siRNA on primary cultured neurons. Size & content: – GenMute™ Reagent, 1.0 ml, sufficient for ~833 reactions based on transfecting 25 pmoles siRNA or miRNA mimics in 24-well p...
¥2,680.00

... 更多信息


SL100568-RAW

GenMute™ siRNA Transfection Reagent for RAW 264.7 Cell

Description: GenMute™ siRNA Transfection Reagent for RAW 264.7 Cell is pre-optimized for transfecting siRNA to RAW 264.7 cells. RAW 264.7 cells are a macrophage-like, Abelson leukemia virus transformed cell line derived from BALB/c mice. RAW 264.7 cell slide is often used for immunocytochemical analysis of protein and protein-protein interaction. Procedures for immunohistochemistry can be directly applied. Size & content: – GenMute™ Reagent, 1.0 ml, sufficient for ~833 reactions ba...
¥1,980.00

... 更多信息


SL100568-SMC

GenMute™ siRNA Transfection Reagent for Smooth Muscle Cells

Description: GenMute™ siRNA Transfection Reagent for SMC is pre-optimized for transfecting siRNA to smooth muscle cells (SMC). Refer to the following optimal transfection conditions for maximal silencing on SMC. GenMute™ reagent, 1.0 ml, is sufficient for ~833 transfections in 24 well plates or ~416 transfections in 6 well plates. Summary of Optimal Transfection Conditions: Cell culture medium Confluency of cell on the day of transfection Optimal siRNA concentration Diluent for siRNA an...
¥1,980.00

... 更多信息


SL100568-U2OS

GenMute™ siRNA Transfection Reagent for U2OS Cell

Description: GenMute™ siRNA Transfection Reagent for U2OS Cell is pre-optimized for transfecting siRNA to U2OS cells. The U2OS cell line, originally known as the 2T line, was cultivated from the bone tissue of a fifteen-year-old human female suffering from osteosarcoma. Established in 1964, the original cells were taken from a moderately differentiated sarcoma of the tibia. U2OS cells exhibit epithelial adherent morphology and viruses were not detected in the line during co-cultivation with ...
¥1,980.00

... 更多信息





版权所有 © 2024 思科生物科技有限公司.